Regeneron Pharmaceuticals...

685.26
-13.48 (-1.93%)
At close: Mar 03, 2025, 3:59 PM
684.00
-0.18%
After-hours: Mar 03, 2025, 04:09 PM EST

Regeneron Pharmaceuticals Cash Flow Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03 FY02 FY01 FY00 FY99 FY98 FY97 FY96 FY95 FY94 FY93 FY92 FY91
Net Income 4.41B 3.95B 4.34B 8.08B 3.51B 2.12B 2.44B 1.2B 895.52M 636.06M 348.07M 424.36M 750.27M -221.76M -104.47M -67.83M -82.71M -105.6M -102.34M -95.45M 41.7M -107.46M -124.38M -76.18M -23.21M -23.1M -8.6M -11.6M -32.4M -23.5M -30.7M -39.9M -19.1M -4.5M
Depreciation & Amortization 482.9M 421M 341.4M 286.2M 235.9M 210.3M 148.2M 145.47M 104.75M 74.91M 52.69M 41.2M 36.94M 31.08M 19.69M 14.25M 11.29M 11.49M 14.59M 15.5M 15.36M 12.94M 8.45M 6.08M 4.42M 3.4M 3M 4.4M 6.1M 5.9M 4.2M 3.1M 2M 800K
Stock-Based Compensation 982.8M 885M 725M 601.7M 432M 464.3M 427.4M 507.28M 559.88M 459.05M 307.24M 198.4M 94.16M 56.09M 39.9M 31.26M 32.52M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Working Capital -179.7M -82.2M -116.2M -360.9M 263M 163.6M -250.2M -226.43M 267.81M 529.42M -18.66M -80.74M -41.08M 3.65M 168.48M -27.5M -35.54M 87.47M 89.36M 26.54M -65.66M 85.38M 5.31M 11.96M -19.3M 5.2M -7.4M -2.6M -8.5M -14.8M n/a n/a n/a n/a
Other Non-Cash Items -82.2M 266.3M 599.8M 181.7M -135M -29.3M 12.1M -36.9M 485.7M 619.82M 361.62M 133.65M -861.82M 10.37M 293K -382K 2.25M 34.02M 17.86M 21.86M -15.23M 4.06M 1.82M 1.77M 6.14M 4.7M 2.8M 3.7M 14.5M 14.2M 9M 3.6M -1.6M -2.5M
Deferred Income Tax -757.3M -837.8M -746.4M -147.1M 75.6M -130.6M -140M 318.81M -360.08M -121.62M -66.6M 63.6M -340.16M n/a n/a -56K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital -618.3M -94.1M -243.3M -1.92B -1.5B -200.5M -697M -926.53M 228.19M 229.83M 20.24M -190.67M -672.8M -17.46M 140.94M -49.47M -52.43M 87.47M 92.96M 27.79M -58.74M 84.33M 3.58M 11.02M -15.25M 1.2M -7.4M -2.6M -8.5M -14.8M -3M 3.1M 1.5M -600K
Operating Cash Flow 4.42B 4.59B 5.01B 7.08B 2.62B 2.43B 2.2B 1.31B 1.49B 1.33B 752.43M 588.6M -74.61M -141.68M 96.34M -72.23M -89.09M 27.37M 23.07M -30.3M -16.91M -6.13M -110.52M -57.32M -27.91M -13.8M -10.2M -6.1M -20.3M -18.2M -20.5M -30.1M -17.2M -6.8M
Capital Expenditures -755.9M -926.4M -590.1M -551.9M -614.6M -429.6M -383.1M -272.6M -511.9M -677.93M -333.01M -156.32M -49.34M -57.22M -99.69M -97.32M -34.86M -18.45M -2.81M -4.96M -6.17M -29.66M -34.37M -8.22M -6.5M -5.7M -3M -2.1M -8.6M -3.3M -6.9M -10.2M -2.1M -1M
Acquisitions -16.5M -54.9M -230.3M 551.9M 614.6M 429.6M 1.07B n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments -16.62B -11.65B -7.49B -7.05B -3.24B -3.2B -1.85B -1.28B -809.42M -557.11M -564.19M -577.28M -470.39M -240.39M -612.19M -200M -581.14M -594.45M -456.89M -102.99M -276.32M -287.5M -239.98M -191.35M -104.9M -60.1M -88M -112.6M -74.6M -28.1M -22.5M -77.3M -71.6M -137.2M
Sales Maturities Of Investments 15.03B 9.44B 5.55B 2.22B 3.79B 1.6B 775.6M 544.58M 274.46M 327.44M 476.42M 378.15M 439.21M 426.36M 276.6M 297.41M 646.86M 527.17M 306.2M 223.45M 277.91M 253.31M 215.83M 124.19M 53.72M 83.2M 93.5M 75.9M 38.9M 38.8M 61.3M 68.5M 82.8M 61.8M
Other Investing Acitivies -105.6M -926.4M -1.03B -551.9M -614.6M -429.6M -1.08B -732.6M -534.9M -229.67M -87.77M -199.13M -31.74M -277K 1.12M 50K -50K n/a -1.6M n/a n/a n/a n/a n/a n/a 100K -100K -100K n/a n/a n/a -4.6M -900K -1.2M
Investing Cash Flow -2.47B -3.19B -3.78B -5.38B -70.6M -2.03B -1.46B -1.01B -1.05B -907.6M -420.78M -355.45M -81.07M 128.47M -434.15M 146K 30.82M -85.72M -155.1M 115.49M -4.58M -63.84M -58.52M -75.39M -57.68M 17.5M 2.4M -38.9M -44.3M 7.4M 31.9M -23.6M 8.2M -77.6M
Debt Repayment n/a n/a n/a n/a 1.98B n/a n/a 37.1M -40.6M -140.45M -221.73M -2.02M -2.2M 389.44M 46.52M 22.77M -200.81M n/a n/a n/a 3.83M 13.51M -426K 190.6M -1.5M -1.1M -1.9M -3.9M -3.7M -3.3M -300K -1.2M -800K -100K
Common Stock Repurchased -3.63B -2.94B -2.53B -2.68B -6.53B -463.9M -191.6M -301.7M -143.2M -160.54M -267.58M -195.09M -163.3M -25.08M -3.8M n/a n/a n/a n/a n/a -888K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies -33.4M n/a n/a n/a n/a n/a n/a n/a -643.29M -168.17M 154M 216.86M 4.31M -23.7M n/a n/a n/a n/a 390K n/a n/a n/a n/a n/a n/a n/a n/a -100K n/a n/a 100K -100K n/a n/a
Financial Cash Flow -2.2B -1.79B -1.01B -1.01B -1.97B -252.1M -77.1M -24.4M -700.39M -262.8M -209.27M 77.14M -97.65M 384.25M 243.31M 31.36M -192.86M 319.4M 185.4M 4.08M 4.44M 108.18M 1.72M 349.12M 92.87M 300K -1.4M 39.4M 66.3M 19.9M -200K 49.8M -800K 91.5M
Net Cash Flow -248.8M -381.6M 221.3M 690.8M 577M 150.1M 655M 277.53M -273.9M 160.38M 113.11M 305.33M -253.33M 371.04M -94.5M -40.72M -251.13M 261.05M 53.37M 89.28M -17.05M 38.21M -167.32M 216.41M 7.28M 3.9M -9.2M -5.6M 1.7M 9.1M 11.2M -3.9M -9.8M 7.1M
Free Cash Flow 3.66B 3.67B 4.42B 6.53B 2B 2B 1.81B 1.03B 974M 652.85M 419.43M 432.27M -123.95M -198.9M -3.35M -169.55M -123.94M 8.93M 20.26M -35.26M -23.08M -35.79M -144.89M -65.54M -34.41M -19.5M -13.2M -8.2M -28.9M -21.5M -27.4M -40.3M -19.3M -7.8M